Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
IMRX
#3221
Immuneering Corporation Class A Common Stock
5.4
1
USD
-5.09%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-5.09%
Aylık Değişim
+7.13%
6 aylık değişim
-9.53%
Yıllık Değişim
+300.74%
Önceki Kapanış
5.7
0
Open
5.4
1
Bid
Ask
Low
5.4
1
High
5.4
1
Hacim
55
Piyasalar
ABD Borsası
Sağlık Hizmetleri
IMRX
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
26.38 M
26.44 M
29.28 M
35.89 M
64.65 M
—
Valuation ratios
Enterprise value
351.63 M
33.37 M
154.95 M
42.81 M
296.77 M
636.07 M
Price to earnings ratio
-6.57
-2.11
-3.89
-1.08
-5.18
-11.64
Price to sales ratio
105.83
333.84
—
3 435.39
—
—
Price to cash flow ratio
-7.13
-2.4
-4.25
-1.2
-6.39
-14.23
Price to book ratio
1.41
0.96
2.3
1.59
1.33
2.96
Enterprise value to EBITDA ratio
-35.6
-4.77
-9.88
-3.15
-19.43
-44.46
Profitability ratios
Return on assets %
-0.2
-0.41
-0.52
-1.16
-0.24
-0.77
Return on equity %
-0.22
-0.46
-0.59
-1.47
-0.26
-0.98
Return on invested capital %
-917.13
-1 049.04
-619.87
-1 405.29
-441.24
—
Gross margin %
44.56
50.11
—
100
—
—
Operating margin %
-1 629.17
-16.33 K
—
-333.71 K
—
—
EBITDA margin %
-1 626.98
-16.24 K
—
-331.75 K
—
—
Net margin %
-1 612.33
-15.94 K
—
-317.9 K
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
27.04
13.5
11.35
5.28
17.5
52.68
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-2.27
-1.67
-1.72
-1.83
-1.03
-1.18
EBIT per share
-2.49
-1.96
-2.06
-2.14
-1.35
-1.55
EBITDA per share
-2.49
-1.95
-2.08
-2.12
-1.34
-1.54
Total debt per share
—
—
—
—
—
—
Cash per share
10.96
4
3.01
1.21
2.92
10.4
Net current asset value per share
11.19
4.12
3.13
1.32
4
11.63
Tangible book value per share
10.93
3.89
2.94
1.15
4.8
11.96
Working capital per share
10.78
3.82
2.86
1.07
3.78
10.8
Book value per share
11.46
4.16
3.19
1.38
4.96
12.69
Haberler
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts - TipRanks.com
Piper Sandler, Immuneering hissesi için hedef fiyatı düşürdü
Piper Sandler cuts Immuneering stock price target on launch timing
Oppenheimer, boru hattı ilerlemesi sonrası Immuneering hisse tavsiyesini korudu
Oppenheimer reiterates Immuneering stock rating on pipeline progress
Immuneering’s (IMRX) chief business officer buys $24,990 in stock
Immuneering yöneticisi Schall 101.041 dolar değerinde hisse satın aldı
Immuneering’in İnsan Kaynakları Yöneticisi Neufeld, IMRX’ten 10.905 dolar değerinde hisse alıyor
Immuneering yöneticisi Feinberg 86 bin dolarlık hisse alımı gerçekleştirdi
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.55%